Genetic studies of diabetes following the advent of the genome-wide association study: where do we go from here? by Frayling, T, McCarthy, M

Allele loss in colorectal cancer at the Cowden disease/juvenile polyposis locus on 10q. by Frayling, I, Bodmer, W, Tomlinson, I

The role of the HNF4alpha enhancer in type 2 diabetes. by Mitchell, S, Gloyn, A, Owen, K, Hattersley, A, Frayling, T

The role of the HNF4α enhancer in type 2 diabetes variants of the HNF4α enhancer are not a common cause of susceptibility to type 2 diabetes by Mitchell, S, Gloyn, A, Owen, K, Hattersley, A, Frayling, T

Frequency of germline hereditary non-polyposis colorectal cancer gene mutations in patients with multiple or early onset colorectal adenomas. by Beck, N, Tomlinson, I, Homfray, T, Frayling, I, Hodgson, S, Bodmer, W

Molecular testing for somatic cancer mutations: a survey of current and future testing in UK laboratories. by Wordsworth, S, Papanicolas, I, Buchanan, J, Frayling, I, Taylor, J, Tomlinson, I

Current and future molecular testing of cancers: A survey of UK laboratories by Papanicolas, I, Wordsworth, S, Buchanan, J, Taylor, J, Frayling, I, Tomlinson, I

Loss of heterozygosity at APC and beta-catenin expression in sporadic colorectal carcinogenesis by Hao, X, Frayling, I, Willcocks, T, Tomlinson, I, Pignatelli, M, Talbot, I

Molecular testing for somatic mutations in common cancers: the views of UK oncologists. by Wordsworth, S, Buchanan, J, Papanicolas, I, Taylor, J, Frayling, I, Tomlinson, I

The NF1 somatic mutational landscape in sporadic human cancers by Charlotte Philpott, Hannah Tovell, Ian M. Frayling, David N. Cooper, Meena Upadhyaya

Get full text

Use of SSCP analysis to identify germline mutations in HNPCC families fulfilling the Amsterdam criteria. by Beck, N, Tomlinson, I, Homfray, T, Frayling, I, Hodgson, S, Harocopos, C, Bodmer, W

Calcium/calmodulin dependent protein kinase II genes: Genomic structure and screening for variants in subjects with Type 2 diabetes by Gloyn, A, Desai, M, Clark, A, Holman, R, Frayling, T, Hattersley, A, Ashcroft, S

Interrogating type 2 diabetes genome-wide association data using a biological pathway-based approach. by Perry, JR, McCarthy, M, Hattersley, A, Zeggini, E, Weedon, M, Frayling, T

Cerebral primitive neuroectodermal tumor in an adult with a heterozygous MSH2 mutation. by Jeans, A, Frayling, I, Jasani, B, Side, L, Blesing, C, Ansorge, O

Is the thrifty genotype hypothesis supported by evidence based on confirmed type 2 diabetes- and obesity-susceptibility variants? by Southam, L, Soranzo, N, Montgomery, S, Frayling, T, McCarthy, M, Barroso, I, Zeggini, E

The spectrum of p53 mutations in colorectal adenomas differs from that in colorectal carcinomas. by Hao, X, Frayling, I, Sgouros, J, Du, M, Willcocks, T, Talbot, I, Tomlinson, I

Quantitative traits associated with the Type 2 diabetes susceptibility allele in Kir6.2. by Weedon, M, Gloyn, A, Frayling, T, Hattersley, A, Davey Smith, G, Ben-Shlomo, Y

Beta-catenin expression and allelic loss at APC in sporadic colorectal carcinogenesis. by Hao, X, Frayling, I, Willcocks, T, Han, W, Tomlinson, I, Pignatelli, M, Pretlow, T, Talbot, I

A powerful approach to sub-phenotype analysis in population-based genetic association studies. by Morris, A, Lindgren, C, Zeggini, E, Timpson, N, Frayling, T, Hattersley, A, McCarthy, M

Large-scale type 2 diabetes association analysis of low-frequency nonsynonymous coding variants in the HNF4A gene including up to 17,600 individuals by Mohammadi, B, Groves, C, Herrera, B, Frayling, T, Hattersley, A, Gloyn, A, McCarthy, M